Milestone Scientific Inc (A:MLSS)

Business Focus: Advanced Medical Equipment & Technology

Mar 14, 2024 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables to Omaha Pain...
Feb 28, 2024 08:30 am ET
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with...
Feb 20, 2024 08:30 am ET
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine...
Jan 16, 2024 08:30 am ET
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided the following letter to shareholders from the Company’s CEO, Arjan Haverhals,...
Dec 13, 2023 05:00 pm ET
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000...
Dec 10, 2023 08:33 pm ET
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the pricing of an underwritten public offering of 4,765,000 shares of its common...
Dec 08, 2023 04:03 pm ET
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced an underwritten public offering of shares of its common stock...
Dec 08, 2023 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported it has commenced commercial sales of CompuFlo® disposables for use in neurostimulation...
Nov 28, 2023 08:30 am ET
Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has entered into an agreement with Bioline Supply to distribute the CompuFlo®...
Nov 15, 2023 07:00 am ET
Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended...
Nov 10, 2023 08:30 am ET
Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November...
Nov 09, 2023 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into Island Ambulatory...
Sep 12, 2023 11:00 am ET
Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dr. Didier Demesmin, MD, MBA, to the Board of Directors. Dr....
Aug 15, 2023 07:00 am ET
Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June...
Aug 09, 2023 04:05 pm ET
Milestone Scientific Schedules Second Quarter 2023 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, August 15,...
Aug 09, 2023 08:30 am ET
Milestone Scientific Announces Positive Insurance Payment for the CompuFlo® Epidural System
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announces, positive reimbursement was received from three commercial payers for the use of the...
Jun 15, 2023 11:00 am ET
Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that Arjan Haverhals, CEO of Milestone Scientific will be presenting at the Maxim Group...
May 16, 2023 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into The Pain and...
May 11, 2023 07:00 am ET
Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March...
May 10, 2023 08:30 am ET
Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, as well as AI-assisted medical technology, today announced the successful completion of the first...
May 09, 2023 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in Oregon
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into The Sports and Spine...
May 05, 2023 11:00 am ET
Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 11,...
Mar 31, 2023 07:00 am ET
Milestone Scientific Provides 2022 Year-End Business Update
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ending December 31,...
Mar 29, 2023 08:30 am ET
Milestone Scientific Schedules 2022 Year-End Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, March 31,...
Mar 14, 2023 09:15 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the University Pain and Spine Center which Operates 7 Locations Across New Jersey and New York
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into the University...
Mar 10, 2023 09:00 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Three Prominent Colorado Pain Management Clinics
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables across three pain...
Mar 02, 2023 08:30 am ET
Milestone Scientific Granted U.S. Government’s System for Award Management (SAM) Registration of its CompuFlo® Epidural System
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that its CompuFlo® Epidural System has been granted registration with the U.S....
Feb 27, 2023 11:00 am ET
Milestone Scientific Announces 510(k) FDA Clearance for the Use of CompuFlo Epidural System in Thoracic Indications
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that its CompuFlo® Epidural System has received 510(k) FDA clearance for use in the...
Jan 12, 2023 08:30 am ET
Milestone Scientific Announces Distribution Agreement with Leading European Dental Distributor & Manufacturer Sweden & Martina
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced it has entered into a distribution agreement with Sweden & Martina, a leading...
Jan 10, 2023 08:30 am ET
Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced it has entered into a distribution agreement granting TEKMIKA Health Technologies...
Jan 05, 2023 08:15 am ET
Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman as Chairman of the Board of Directors
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Neal Goldman as Chairman of the Board of Directors. Mr. Goldman...
Nov 15, 2022 07:00 am ET
Milestone Scientific Achieves Revenue of $2.2 Million for the Third Quarter of 2022
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended...
Nov 10, 2022 08:30 am ET
Milestone Scientific Schedules Third Quarter 2022 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 15,...
Oct 06, 2022 09:00 am ET
Milestone Scientific to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th
ROSELAND, NJ / ACCESSWIRE / October 6, 2022 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, has been invited to present at the 2022 MicroCap Rodeo Windy City Roundup Conference, which is being held on October 12 - 13, 2022 in Chicago, Illinois.
Sep 27, 2022 09:05 am ET
60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago
RALEIGH, NC / ACCESSWIRE / September 27, 2022 / The 2nd Annual MicroCap Rodeo Conference is going on the road and will take place at the Swissotel in Chicago on October 12th - 13th, 2022, where 60+ SmallCap, MicroCap and NanoCap public companies will be presenting to a global investor audience.
Aug 18, 2022 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables Across Three Departments within UofL Health
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful evaluation, it has commenced sales of its CompuFlo®...
Aug 16, 2022 07:00 am ET
Milestone Scientific Provides Business Update for the Second Quarter of 2022
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June...
Aug 12, 2022 08:30 am ET
Milestone Scientific Schedules Second Quarter 2022 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, August 16,...
Aug 04, 2022 08:30 am ET
Milestone Scientific Announces Distribution Agreement with Clinical Technology, Inc. for the CompuFlo® Epidural System
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it has re-engaged Clinical Technology, Inc. (CTI), a leading specialty...
Aug 02, 2022 08:30 am ET
Milestone Scientific Commences Sales of its CompuFlo® Epidural System to the University of Scranton for Incorporation in their Student Registered Nurse Anesthesia Curriculum
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it has commenced sales of the CompuFlo® Epidural system to the University of...
Jul 19, 2022 08:30 am ET
Milestone Scientific Names Hager & Werken as Exclusive STA Single Tooth Anesthesia System® Distributor in Germany and Austria
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it has entered into a distribution agreement granting Hager & Werken exclusive...
Jul 12, 2022 08:30 am ET
Milestone Scientific Inc. Announces F&M Feed as an Exclusive Distributor in Greece and Commences Sales of CompuFlo® Epidural Instrument
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today signed an exclusive distribution agreement in Greece for the CompuFlo® Epidural System with...
Jul 07, 2022 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables to a Leading Medical Center in Southern California
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful trial and evaluation, it has commenced sales of its...
Jul 06, 2022 11:00 am ET
American Medical Association Issues Technology-Specific CPT® Code for Milestone Scientific’s CompuFlo Epidural System
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that the American Medical Association (AMA) has issued a new technology-specific...
May 27, 2022 08:00 am ET
Milestone Scientific Expands Medical Indications for the CompuFlo® Epidural Instrument and Commences Disposable Sales to a Leading Veterinary and Academic Institution
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that it has commenced sales of its CompuFlo® Epidural instrument disposables at a...
May 23, 2022 08:00 am ET
Milestone Scientific Announces the Appointment of Retail Industry Veteran Ms. Benedetta Casamento to its Board of Directors
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Ms. Benedetta Casamento to the Company’s Board of Directors....
May 17, 2022 07:00 am ET
Milestone Scientific Achieves Revenue of $2.7 Million and Provides Business Update for the First Quarter of 2022
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March...
May 13, 2022 11:00 am ET
Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, May 17,...
Apr 29, 2022 01:16 pm ET
Milestone Scientific to Present at Investor Summit Group's Q2 In-Person Conference on May 3rd in NYC
Roseland, New Jersey--(Newsfile Corp. - April 29, 2022) - Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, President and CEO of Milestone Scientific, will present at The Q2 Investor Summit, hosted by the Investor Summit Group, being held on May 3-4, 2022 at The Westin New York Grand Central.
Apr 14, 2022 11:00 am ET
Milestone Scientific to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, President and CEO of Milestone Scientific, will present at the...
Apr 14, 2022 07:30 am ET
Milestone Scientific Enacts Strategy to Diversify Channel Partnerships and Announces Initiatives to Expand Dental Sales
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today announced it has expanded its dental strategy, entering the growing dental implant...
Apr 11, 2022 08:30 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that, following a successful trial and evaluation, it has commenced sales of its...
Apr 01, 2022 07:00 am ET
Milestone Scientific Reports 90% Year-Over-Year Revenue Growth and Provides 2021 Year-End Business Update
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the full year ending December...
Mar 29, 2022 02:00 pm ET
Milestone Scientific Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, April 1, 2022...
Mar 29, 2022 09:00 am ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Two Premier Pain Clinics
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it has commenced sales of the CompuFlo® Epidural disposables at the Cypress...
Feb 07, 2022 09:00 am ET
Milestone Scientific to Present at MicroCap Rodeo’s Winter Wonderland Best Ideas Conference on Wednesday, February 9
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that the Company has been invited to present at The MicroCap Rodeo’s 2nd Annual...
Jan 28, 2022 10:07 am ET
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
Jan 18, 2022 08:30 am ET
Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today announced that Arjan Haverhals, CEO and president of Milestone Scientific, will...
Jan 10, 2022 08:30 am ET
Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today provided revenue guidance for the fourth quarter and year ended December 31, 2021....
Jan 07, 2022 09:00 am ET
Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will be...
Jan 06, 2022 02:30 pm ET
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Physician
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Dr. Harsh Govil, MD, MPH, whose practice is based in Statesville, NC, has begun...
Dec 28, 2021 08:30 am ET
Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier Hospitals
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced the purchase of its CompuFlo® Epidural and CathCheck™ Verification System...
Dec 23, 2021 08:30 am ET
Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in North America
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it has entered into an agreement with Andau Medical to distribute the STA Single...
Dec 22, 2021 11:00 am ET
Milestone Scientific Announces Purchase Agreement for its CompuFlo® Epidural / CathCheck™ Verification System Disposables with a Premier Northeast Teaching Hospital
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported, that following a successful trial, it has signed an agreement for the purchase of...
Dec 15, 2021 04:05 pm ET
Milestone Scientific CEO Arjan Haverhals to Participate in the Benzinga All Access Event on December 16th
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific,...
Dec 01, 2021 08:30 am ET
Dr. Miguel de la Garza, President of the Florida Society of Interventional Pain Physicians and Renowned Physician at Surgery Partners, Adopts Milestone Scientific’s CompuFlo® Epidural Instrument for P
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Dr. Miguel de la Garza has begun incorporating the CompuFlo® Epidural...
Nov 15, 2021 07:30 am ET
Milestone Scientific Reports 69% Increase in Revenue for Third Quarter of 2021
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended...
Nov 11, 2021 08:30 am ET
Milestone Scientific Schedules Third Quarter 2021 Business Update Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, November 15,...
Oct 18, 2021 08:30 am ET
Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific,...
Oct 14, 2021 08:30 am ET
Milestone Scientific Announces International Expansion for their CompuFlo® Epidural Instrument
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that it has added three new international distributors for the CompuFlo Epidural...
Oct 05, 2021 09:00 am ET
Milestone Scientific to Present at Microcap Rodeo’s Fall Harvest - Best Ideas from the Buy-Side on Wednesday, October 6, 2021
ROSELAND, NJ / ACCESSWIRE / October 5, 2021 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that the Company has been invited to present at the Fall Harvest - Best Ideas from the Buy-Side conference, which is being held virtually on October 5 - 8, 2021. Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will present at the conference.
Oct 04, 2021 04:30 pm ET
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
Oct 04, 2021 08:30 am ET
Milestone Scientific Approved as Vendor to Supply CompuFlo® Epidural/ CathCheck™ Verification System Across Florida’s Memorial Heathcare System
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that Memorial Regional Hospital in Hollywood, Fla., has begun the use of the CompuFlo...
Aug 16, 2021 07:30 am ET
Milestone Scientific Reports Fourteen-Fold Increase in Revenue for Second Quarter of 2021
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June...
Aug 11, 2021 12:00 pm ET
Milestone Scientific Schedules Second Quarter 2021 Business Update Conference Call
Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on...
Jul 07, 2021 08:00 am ET
Milestone Scientific Commences Sales of CompuFlo® / CathCheck™ Disposables within the UTMB Health Clear Lake Campus Hospital
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported that the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital...
Jun 23, 2021 12:00 pm ET
Milestone Scientific Expands Medical Sales Team to Capitalize on Growing Interest in CompuFlo Including Appointment of Senior Industry Sales Executive Chet Trechock as VP of Sales for Medical
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has expanded its medical sales team including the appointment of Chet...
May 27, 2021 07:15 pm ET
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
May 27, 2021 07:15 pm ET
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
May 27, 2021 08:30 am ET
Milestone Scientific to Participate in the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, has been invited to present at the "Summer Solstice – Best Ideas from the Buy-Side" conference, which is...
May 17, 2021 07:30 am ET
Milestone Scientific Reports a 61% Increase in Revenue for Q1 2021
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March...
May 13, 2021 08:00 am ET
Milestone Scientific Announces Promotion of Arjan Haverhals to CEO
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that in connection with the Company’s previously disclosed succession plan: Leonard...
May 12, 2021 10:54 am ET
Milestone Scientific Schedules First Quarter 2021 Business Update Conference Call
Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on...
May 03, 2021 08:30 am ET
Milestone Scientific Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced preliminary financial results for the first quarter...
Apr 01, 2021 07:30 am ET
Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the full year ending December...
Mar 30, 2021 10:28 am ET
Milestone Scientific Schedules 2020 Year-End Business Update Conference Call
Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 4:30 p.m. Eastern Time on...
Mar 12, 2021 07:00 am ET
Milestone Scientific to Present at the Q1 Virtual Investor Summit
via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that Arjan Haverhals, CEO of Wand Dental and...
Mar 10, 2021 03:30 pm ET
Milestone Scientific Receives Notice of Allowance for European Patent Related to Combination of Nerve Stimulation and DPS Dynamic Pressure Sensing Technology® to Optimize Needle Tip Location in Ultras
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has received Notice of Allowance from the European Patent...
Mar 02, 2021 09:30 am ET
Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South Carolina
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has begun selling CompuFlo® / CathCheck™ disposables to the...
Feb 24, 2021 03:15 pm ET
Milestone Scientific Inc. Announces Breakthrough CompuPulse System and Receives Notice of Allowance for U.S. Patent
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has received a Notice of Allowance from the United States...
Feb 23, 2021 09:30 am ET
Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural Instruments and Disposables to University Hospital of Würzburg in Germany
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has begun selling its CompuFlo® Epidural Instrument and...
Feb 16, 2021 03:00 pm ET
Milestone Scientific Adds Three Additional Premier Distributors Providing Robust U.S. Coverage and a New Distributor in Canada for the Company’s Dental Instrument
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has signed three additional distribution agreements in...
Feb 12, 2021 08:30 am ET
Milestone Scientific to Participate in the Winter Wonderland Conference- Best Ideas from the Buy-Side
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, announced that it will be presenting at the Winter Wonderland Conference, hosted by The MicroCap Rodeo, being...
Feb 09, 2021 08:30 am ET
Milestone Scientific Continues Expansion of Distributor Network for Dental Instrument in the US; Adds Two Additional Independent Distributors Covering Atlanta and Tennessee
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has signed two additional distribution agreements with...
Jan 20, 2021 03:00 pm ET
Milestone Scientific Inc. Receives Notice of Allowance for U.S Patent Related to CompuFlo® Disposables
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has received a Notice of Allowance from the United States...
Jan 19, 2021 08:30 am ET
Milestone Scientific Inc. Announces It has Begun Implementing Three-Year Strategy to Expand the World-Wide Global Dental Market
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, today announced that it has signed agreements with US Dental Depot and IQ Dental...
Jan 12, 2021 09:00 am ET
Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural and CathCheck Disposables to Regional Medical Center (RMC), a Premier Regional Healthcare System
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has begun selling CompuFlo® Epidural and CathCheck...
Jan 11, 2021 09:00 am ET
Milestone Scientific Inc. Announces Agreement with Bitmedical AG to Distribute the CompuFlo® Epidural Instrument Across Austria and Switzerland
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has entered into an agreement with Bitmedical AG...
Jan 11, 2021 08:00 am ET
Milestone Scientific Inc. CEO Increases Stock Ownership through Option Exercise
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today reported that the Company’s Interim CEO, Leonard Osser, completed the sale...
Jan 06, 2021 09:30 am ET
Milestone Scientific Inc. Raises Revenue Guidance to Over $2 Million for Q4 2020
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today raised revenue guidance to over $2 million for the fourth quarter of 2020,...
Jan 05, 2021 08:28 am ET
Milestone Scientific, Inc. Unveils Study Findings: Where Is Anesthesiology Headed?
ROSELAND, N.J., Jan. 5, 2021 /PRNewswire/ -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, has announced the results of a detailed survey amongst Board Certified Anesthesiologists in the US.  The survey was conducted to better understand where the profession of anesthesiology is today and where anesthesiologists believe it should go in the future.
Jan 04, 2021 09:00 am ET
Milestone Scientific Inc. Announces Entrée into the Nationally Recognized University of Texas Medical Branch at Galveston with its CompuFlo Disposables
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that as per a purchase order the Company received in late 2020,...
Dec 16, 2020 08:00 am ET
Milestone Scientific Inc. CEO to Increase Stock Ownership through Option Exercise
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today reported that the Company’s Interim CEO, Leonard Osser, plans to exercise...
Nov 30, 2020 02:00 pm ET
Milestone Scientific Inc. Reports Continued Growth in Dental Sales
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today provided an update on the expected growth in dental sales during the fourth...
Nov 17, 2020 08:00 am ET
Milestone Scientific Reports Seven-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter and nine...
Nov 11, 2020 08:30 am ET
Milestone Scientific to Present at the Virtual Fall Investor Summit on November 18th
ROSELAND, NJ / ACCESSWIRE / November 11, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the Virtual Fall Investor Summit to be held virtually on November 16-18, 2020.
Nov 03, 2020 08:30 am ET
Milestone Scientific Schedules Third Quarter 2020 Conference Call
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, November 17,...
Oct 22, 2020 09:00 am ET
Milestone Scientific Inc. Publishes Video Interview with Dr. Ayman A. Alian, Division Chief of Obstetric & Gynecological Anesthesiology at Yale School of Medicine
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, reports it has published a video interview with Dr. Ayman A. Alian, MBChB,...
Oct 13, 2020 10:00 am ET
Milestone Scientific Inc. Awarded Group Purchasing Agreement with Premier for CompuFlo® Epidural System and CathCheck™
Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, today announced that it has been awarded a group purchasing agreement for the...
Oct 08, 2020 03:30 pm ET
The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020
NEW YORK, NY / ACCESSWIRE / October 8, 2020 / The MicroCap Rodeo continues this year with its first virtual event set for October 13-16, 2020. This year' "Best Ideas" conference focuses solely on 25 public companies recommended by institutional investors and qualified individual investors. The event will feature 2 days of company presentations followed by 2 days of pre-scheduled 1-1's.
Oct 01, 2020 08:00 am ET
Milestone Scientific Inc. Projects Over Five-Fold Sequential Increase in Dental Sales for Q3 2020 Versus Q2 2020
Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that it projects sales for the third quarter ending September 30, 2020...
Sep 10, 2020 08:30 am ET
Milestone Scientific to Hold Investor Webinar and Q&A Session with CEO on September 14
ROSELAND, NJ / ACCESSWIRE / September 10, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that Leonard Osser, Interim Chief Executive Officer, will share insight into the company's recent developments and upcoming milestones during an investor webinar on Monday, September 14, 2020 at 4:00 p.m. ET. A live Q&A session with Mr. Osser will follow the presentation.
Sep 09, 2020 08:00 am ET
Sep 01, 2020 08:30 am ET
Milestone Scientific Promotes Arjan Haverhals to President of Milestone Scientific
ROSELAND, NJ / ACCESSWIRE / September 1, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has promoted Jan Adriaan (Arjan) Haverhals to President of Milestone Scientific, replacing Brent Johnston. Mr. Haverhals will continue to serve as President and Chief Executive Officer of the Company's Wand Dental, Inc. subsidiary.
Aug 31, 2020 05:00 pm ET
LD Micro - 360 Companies - Set to Present this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Aug 27, 2020 08:30 am ET
Milestone Scientific to Present at The LD 500 Virtual Conference on September 1st
ROSELAND, NJ / ACCESSWIRE / August 27, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020.
Aug 17, 2020 07:00 am ET
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2020
ROSELAND, NJ / ACCESSWIRE / August 17, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter and six months ending June 30, 2020.
Aug 13, 2020 08:30 am ET
Milestone Scientific Schedules Second Quarter 2020 Conference Call
LIVINGSTON, NJ / ACCESSWIRE / August 13, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, August 17, 2020 to discuss the Company's financial results for the second quarter ended June 30, 2020, as well as the Company's corporate progress and other developments.
Aug 05, 2020 09:00 am ET
LD Micro - Announces Preliminary List of Presenters for the LD 500
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Jun 30, 2020 12:30 pm ET
Milestone Scientific Announces Closing of $14.6 Million Offering of Common Stock and Warrants
ROSELAND, NJ / ACCESSWIRE / June 30, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $2.15. Gross proceeds befo
Jun 29, 2020 08:00 am ET
Milestone Scientific Added to Russell 3000(R) and Russell Microcap(R) Indexes
ROSELAND, NJ / ACCESSWIRE / June 29, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has been added to the Russell 3000® and Russell Microcap® Indexes, following the annual Russell indexes reconstitution, effective after the market open on June 29, according to a final list of additions posted on June 26.
Jun 25, 2020 11:03 pm ET
Milestone Scientific Announces Pricing of $14.0 Million Offering of Common Stock and Warrants
ROSELAND, NJ / ACCESSWIRE / June 25, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the pricing of an underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of its common stock. Each share of common stock is being sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $2.15. Gross proceeds before underwriting discounts and commissi
Jun 25, 2020 04:10 pm ET
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
ROSELAND, NJ / ACCESSWIRE / June 25, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it intends to offer for sale a combination of shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. The company intends to use the net proceeds from this offering for manufacturing, marketing, sales and distribution of its CompluFlo® Epidural System and development of new products and new product uses, wo
Jun 03, 2020 09:00 am ET
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9th-12th, connecting 47 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below along with webcasting links to view presentations.
Jun 03, 2020 09:00 am ET
Milestone Scientific to Present at the Virtual Summer Summit on June 9th
ROSELAND, NJ / ACCESSWIRE / June 3, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will be presenting at the 2020 Virtual Summer Summit being held on June 9th-12th.
Jun 02, 2020 08:30 am ET
Milestone Scientific Appoints Senior Industry & Sales Executive Arjan Haverhals as President & CEO of Wand Dental Inc. Subsidiary
Mr. Haverhals to also help drive sales and marketing initiatives for CompuFlo® Epidural Instrument
May 29, 2020 08:30 am ET
Milestone Scientific Interview to Air on Bloomberg International on the RedChip Money Report
LIVINGSTON, NJ / ACCESSWIRE / May 29, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced an interview with its interim-CEO, Leonard Osser, will air on The RedChip Money Report television program. The interview will air Sunday, May 31, at 3 p.m. local time on Bloomberg International, available in 100+ million homes across Europe.
May 22, 2020 03:00 pm ET
Milestone Scientific Regains Compliance with New York Stock Exchange Listing Standards
LIVINGSTON, NJ / ACCESSWIRE / May 22, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today confirms that it regained compliance with the stockholder's equity requirements under the continued listing standards of the NYSE American LLC ("Exchange").
May 22, 2020 09:15 am ET
Red Chip to Host Investor Webinar and Q&A Session with Milestone Scientific CEO on May 26
LIVINGSTON, NJ / ACCESSWIRE / May 22, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Red Chip will host an investor webinar and Q&A session with Leonard Osser, Interim Chief Executive Officer, to discuss the company's recent developments and upcoming milestones. The investor webinar will be held on Tuesday, May 26, 2020 at 11:00 a.m. ET. A live Q&A session with Mr. Osser will follow the presentation.
May 18, 2020 07:00 am ET
Milestone Scientific Provides Business Update for the First Quarter of 2020
Reports positive feedback and growing interest in CathCheck™
May 13, 2020 02:00 pm ET
Milestone Scientific Announces Publication of Study Validating Efficacy of CompuFlo(R) CathCheck(TM) System to Confirm and Monitor the Placement of an Epidural Catheter
Pressure waveform recording through the epidural catheter resulted in 100% sensitivity and specificity, as well as a positive predictive value of 100%
May 13, 2020 08:30 am ET
Milestone Scientific Schedules First Quarter 2020 Conference Call
LIVINGSTON, NJ / ACCESSWIRE / May 13, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, May 18, 2020 to discuss the Company's financial results for the first quarter ended March 31, 2020, as well as the Company's corporate progress and other developments.
Apr 29, 2020 01:00 pm ET
Milestone Scientific Schedules Conference Call to Discuss Recent Developments Related to its CompuFlo Epidural System
LIVINGSTON, NJ / ACCESSWIRE / April 29, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a business update conference call at 11:00 AM Eastern Time on Tuesday, May 5, 2020 to discuss recent developments related to the Company's CompuFlo Epidural System. Interested parties may ask live questions or submit questions in advance by emailing [email protected].
Apr 21, 2020 10:00 am ET
Milestone Scientific Announces Validation and Integration of CathCheck(TM) Feature into the CompuFlo(R) Epidural System
CathCheck™ verifies catheter placement within seconds saving institutions time and money while improving patient experience
Apr 17, 2020 10:30 am ET
Milestone Scientific Announces Successful Economic Study Comparing Total Costs of CompuFlo(R) Epidural System Versus Traditional Epidural Loss of Resistance Technique
LIVINGSTON, NJ / ACCESSWIRE / April 17, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computer-controlled drug delivery systems that provide painless and precise injections, today reported that a study titled: "Cost Effectiveness Analysis of Two Labor Epidural Analgesia Techniques; Real-Time Pressure Sensing Technology and Traditional Technique," has been electronically presented for the American Society of Regional Anesthesia and Pain Medicine (ASRA). The poster was originally planned for live pre
Apr 15, 2020 03:00 pm ET
Milestone Scientific Announces Validation and Implementation of Quick Start to the CompuFlo Epidural System
LIVINGSTON, NJ / ACCESSWIRE / April 15, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has validated the new "Quick Start," which has been implemented into the CompuFlo® Epidural System. The Quick Start feature simplifies and provides an alternative pathway to reduce the procedure preparation time for the CompuFlo® instrument prior to the procedure.
Apr 14, 2020 12:10 pm ET
Milestone Scientific Announces Closing of Above Market $4.7 Million Offering of Common Stock and Warrants
ROSELAND, NJ / ACCESSWIRE / April 14, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that on April 14, 2020 it closed its previously announced underwritten offering of 4,750,000 shares of its common stock and warrants to purchase up to an aggregate of 2,375,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $0.95. Gross proceeds be
Apr 09, 2020 08:45 am ET
Milestone Scientific Announces Pricing of Above Market $4.5 Million Offering of Common Stock and Warrants
ROSELAND, NJ / ACCESSWIRE / April 9, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the pricing of an underwritten offering of 4,750,000 shares of its common stock and warrants to purchase up to an aggregate of 2,375,000 shares of the its common stock. Each share of common stock is being sold together with a warrant to purchase 0.50 of one share of common stock at a combined price to the public of $0.95. Gross proceeds before underwriting discounts and comm
Apr 08, 2020 05:00 pm ET
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
ROSELAND, NJ / ACCESSWIRE / April 8, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it intends to offer for sale a combination of shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. The company intends to use the net proceeds from this offering for manufacturing, marketing, sales and distribution of its CompluFlo® Epidural System and development of new products and new product uses, wo
Mar 30, 2020 04:05 pm ET
Milestone Scientific Provides 2019 Year-End Business Update; Reports Progress on Commercial Rollout of CompuFlo Epidural System
LIVINGSTON, NJ / ACCESSWIRE / March 30, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ended December 31, 2019.
Mar 30, 2020 10:05 am ET
Milestone Scientific Schedules 2019 Year-End Earnings Conference Call
LIVINGSTON, NJ / ACCESSWIRE / March 30, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, March 31, 2020 to discuss the Company's financial results for the full year ending December 31, 2019, as well as the Company's corporate progress and other developments.
Mar 24, 2020 04:20 pm ET
Milestone Scientific to Present at the Spring Investor Summit on March 25th
LIVINGSTON, NJ / ACCESSWIRE / March 24, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will be presenting at the 2020 Spring Investor Summit being held on March 25th-26th, featuring over 500 registered executives and investors. Due to the ongoing concerns related to COVID-19, the Spring Investor Summit, which was originally scheduled to take place in New York City, will now be hosted virtually.
Feb 25, 2020 08:30 am ET
Milestone Scientific Provides Update on Planned Partnership with RedOne Medical
LIVINGSTON, NJ / ACCESSWIRE / February 25, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today provided an update on its planned partnership with RedOne Medical, a leading medical device distributor and wholesaler serving the Department of Veterans Affairs (VA) medical centers and the Department of Defense (DoD) hospitals, to distribute the Comp
Feb 18, 2020 10:30 am ET
Milestone Scientific Announces CE Mark Approval of Pre-Assembled Disposable Kit for CompuFlo(R) Epidural System in Europe
LIVINGSTON, NJ / ACCESSWIRE / February 18, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced that the new pre-assembled disposable kit for the CompuFlo® Epidural System has received CE Mark approval in Europe through the Company's supplier.
Feb 12, 2020 09:00 am ET
Milestone Scientific Receives Notice of Allowance for European Patent Related to Peripheral Nerve Block Instrument
LIVINGSTON, NJ / ACCESSWIRE / February 12, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has received Notice of Allowance from the European Patent Office (EPO) covering its instrument for performing a peripheral nerve block (PNB). The CompuFlo® with Dynamic Pressure Sensing technology® is the only available device capable of precisely measurin
Feb 05, 2020 09:00 am ET
Milestone Scientific Announces Abstract of CompuFlo(R) Epidural Instrument Integrated with CompuWave Technology Accepted for Presentation at Euroanaesthesia 2020 Congress
LIVINGSTON, NJ / ACCESSWIRE / February 5, 2020 / Milestone Scientific Inc. (NYSE:MLSS) today announced that an abstract, entitled "Confirmation of epidural catheter location by epidural pressure waveform recordings by the CompuFlo® Epidural Instrument (CompuFlo)," has been accepted for presentation at the prestigious Euroanaesthesia 2020 Congress taking place May 30 - June 1, 2020 in Barcelona, Spain. Euroanaesthesia is Europe's largest annual event showcasing the latest news and innovations in the field of anesthesia. The abstract will be presented
Jan 21, 2020 06:59 am ET
Milestone Scientific Receives Notice of Allowance for U.S Patent Related to Cosmetic Injection System
LIVINGSTON, NJ / ACCESSWIRE / January 21, 2020 / Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent regarding a new application for its technology in which claims were allowed for a Computer Controlled Drug Infusion Device for cosmetic use. The all
Jan 16, 2020 08:30 am ET
Milestone Scientific Receives Notice of Allowance on Patent for CompuWave for Integration into CompuFlo(R) Epidural System
Breakthrough technology provides further verification of epidural placement and real-time notification of obstruction or displacement of a catheter
Jan 09, 2020 09:00 am ET
Milestone Scientific Reports Ninth Published Study Reinforcing Efficacy of CompuFlo(R) Epidural Instrument as an Objective Tool to Identify the Epidural Space and Reduce Risk of Accidental Dural Punct
LIVINGSTON, NJ / ACCESSWIRE / January 9, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a new simulation study published in Anesthesiology Research & Practice, in an article entitled: "Epidural Needle Extension through the Ligamentum Flavum Using the Standard versus the CompuFlo®-Assisted Loss of Resistance to Saline Technique: A Simulation Study."
Dec 18, 2019 08:30 am ET
Milestone Scientific Provides Year-End Update on Commercial Rollout of CompuFlo(R) Epidural System
Reports two hospitals now purchasing CompuFlo disposables with many more now trialing the system
Dec 11, 2019 08:00 am ET
Milestone Scientific Partners with RedOne Medical to Distribute the CompuFlo Epidural System to VA and DoD Medical Facilities Worldwide
LIVINGSTON, NJ / ACCESSWIRE / December 11, 2019 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it has partnered with RedOne Medical, a leading medical device distributor and wholesaler serving the Department of Veterans Affairs (VA) medical centers and Department of Defense (DoD) hospitals, to distribute the CompuFlo™ Epidural System.
Nov 20, 2019 11:30 am ET
Milestone Scientific Expands Distribution Agreement Globally with 3B Scientific
CompuFlo® Epidural Trainer now available for anesthesia education worldwide
Nov 14, 2019 04:30 pm ET
Milestone Scientific Reports 17% Increase in Sales for the Third Quarter of 2019
Reports progress on commercial rollout of CompuFlo Epidural System
Nov 12, 2019 08:00 am ET
Milestone Scientific Schedules Third Quarter 2019 Conference Call
LIVINGSTON, NJ / ACCESSWIRE / November 12, 2019 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15, 2019 to discuss the Company's financial results for the third quarter ended September 30, 2019, as well as the Company's corporate progress and other developments.
Oct 21, 2019 02:10 pm ET
Oct 18, 2019 08:30 am ET
Milestone Scientific to Participate at the ANESTHESIOLOGY(R) 2019 Annual Meeting
LIVINGSTON, NJ / ACCESSWIRE / October 18, 2019 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be participating at the ANESTHESIOLOGY® 2019 Annual Meeting being held on October 19th through October 23rd in Orlando, Florida.
Oct 17, 2019 08:30 am ET
International Multicenter Study Finds Milestone Scientific's CompuFlo(R) Epidural System Safe Alternative to Traditional Epidural Method
No accidental dural punctures reported using the CompuFlo® Epidural System Poster Presented at ANESTHESIOLOGY® 2019 Annual Meeting
Sep 04, 2019 08:00 am ET
Aug 15, 2019 08:30 am ET
Milestone Scientific Provide Business Update and Reports Financial Results for the Second Quarter of 2019
LIVINGSTON, NJ / ACCESSWIRE / August 15, 2019 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter and six months ending June 30, 2019.
Aug 12, 2019 08:00 am ET
Milestone Scientific Schedules Second Quarter 2019 Conference Call
LIVINGSTON, NJ / ACCESSWIRE / August 12, 2019 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 16, 2019 to discuss the Company’s financial results for the second quarter ended June 30, 2019, as well as the Company’s corporate progress and other developments.
Aug 05, 2019 09:00 am ET
Milestone Scientific Signs Distribution Agreement with Paragon Care Limited
Expands availability of the CompuFlo® Epidural System to anesthesiologists in Australia
Jun 10, 2019 09:00 am ET
Milestone Scientific's CompuFlo(R) Epidural Instrument Featured in Multiple Abstracts at Euroanaesthesia 2019
Madrid hospital finds CompuFlo a reliable technique for blood patch procedures
Jun 04, 2019 08:30 am ET
Milestone Scientific Announces Conversion of Convertible Preferred Stock at $1.17 per Share
LIVINGSTON, NJ / ACCESSWIRE / June 4, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the shares of Series A Preferred Stock held by BP4 S.p.A., an entity affiliated with Gian Domenico Trombetta, a Director of Milestone Scientific and Chief Executive Officer and Director of Wand Dental Inc., a wholly-owned subsidiary of Milestone Scientific, converted into 5,982,906 shares of restricted common stock common on May 14, 2019 at an effective conversion price of $1.17 per share, based on the initial investment amount of $7 million. The S
May 30, 2019 08:00 am ET
Milestone Scientific Unveils CompuFlo(R) Epidural Trainer and Educational Suite at Euroanaesthesia 2019
Connecting technique and intelligence accelerates clinical competency
May 15, 2019 08:00 am ET
Milestone Scientific Provides Business Update for the First Quarter of 2019
LIVINSTON, NJ / ACCESSWIRE / May 15, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March 31, 2019.
May 14, 2019 11:50 am ET
Milestone Scientific Schedules First Quarter 2019 Conference Call
LIVINGSTON, NJ / ACCESSWIRE / May 14, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16, 2019 to discuss the Company's financial results for the first quarter ended March 31, 2019, as well as the Company's corporate progress and other developments. The Company also announced it plans to report its earnings results pre-market on Wednesday, May 15, 2019.
Apr 19, 2019 07:15 am ET
Investor Expectations to Drive Momentum within Workhorse Group, TRACON Pharmaceuticals, Capricor Therapeutics, Nuverra Environmental Solutions, Milestone Scientific, and Socket Mobile — Discovering Un
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Workhorse Group, Inc. (NASDAQ:WKHS), TRACON Pharmaceuticals, Inc....
Apr 11, 2019 08:00 am ET
Milestone Scientific Showcases the CompuFlo(R) Epidural Instrument at ASRA 2019
Connecting Tactile Feel with Intelligence Improves First Attempt Placement for Any Technique
Apr 08, 2019 08:00 am ET
Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman to Board of Directors
Mr. Goldman also joins newly formed Board special committee established to evaluate strategic options
Apr 04, 2019 08:00 am ET
Milestone Scientific Enters Medical Education Market, Inks Distribution Agreement with American 3B Scientific
New CompuFlo® Epidural Trainer Connects Technique and Intelligence to Improve Trainee Success
Apr 02, 2019 07:30 am ET
Milestone Scientific Reports 70% Year-Over-Year Revenue Growth and Positive Net Income for the Fourth Quarter of 2018
LIVINGSTON, NJ / ACCESSWIRE / April 2, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months and year ended December 31, 2018.
Mar 29, 2019 07:30 am ET
Milestone Scientific Schedules 2018 Year-End Earnings Conference Call
LIVINGSTON, NJ / ACCESSWIRE / March 29, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 3, 2018 to discuss the Company's financial results for the full year ending December 31, 2018, as well as the Company's corporate progress and other developments. The Company also announced it plans to r
Mar 19, 2019 09:00 am ET
Milestone Scientific Announces Plans to Establish Special Committee of the Board of Directors to Evaluate Strategic Options
LIVINGSTON, NJ / ACCESSWIRE / March 19, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the Board of Directors plans to establish a special committee of the Board to evaluate strategic options, which could include the potential sale or licensing of different instruments and/or other business combinations.
Feb 27, 2019 08:00 am ET
Milestone Scientific’s Director of Clinical Affairs Interviewed on Proactiveinvestors.com
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that Dr. Mark Hochman, Director of Clinical Affairs at Milestone Scientific, appeared on...
Feb 20, 2019 08:00 am ET
Milestone Scientific Provides Update on CompuFlo® Epidural System Commercial Launch
Milestone Scientific Inc. (NYSE: MLSS) today reported momentum in the first phase of the commercial roll-out of its CompuFlo® Epidural System. CompuFlo is an instrument that helps anesthesiologists objectively identify the epidural space with 99%...
Feb 14, 2019 08:00 am ET
Milestone Scientific Announces Private Placement by Entity Affiliated with Board Member & CEO of the Company’s Wand Dental Subsidiary
Milestone Scientific Inc. (NYSE: MLSS) today announced that BP4 S.p.A. (“BP4”), a principal stockholder of Milestone Scientific, exercised its right to participate on a pro-rata basis in the recently announced public offering of shares of common...
Feb 07, 2019 09:00 am ET
Third Study Verifies Milestone Scientific’s CompuFlo® Instrument Differentiates False Loss of Resistance During Epidural Blocks
Milestone Scientific Inc. (NYSE: MLSS) today announced a new 120-patient clinical study published in Anesthesiology Research & Practice that verifies the CompuFlo® Epidural System (“CompuFlo”) consistently differentiates false loss of resistance...
Feb 04, 2019 09:20 am ET
Pugliese Ciaccio First Hospital in Italy to Adopt Milestone Scientific’s CompuFlo® Instrument
Milestone Scientific Inc. (NYSE: MLSS) today announced Ospedale “Pugliese Ciaccio” di Catanzaro is the first hospital in Italy to use the CompuFlo® Epidural System (“CompuFlo”) for all epidurals in labor and delivery. For a local hospital...
Feb 01, 2019 08:45 am ET
Milestone Scientific Announces Pricing of $2.0 Million Offering of Common Stock and Warrants
Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today the pricing of an underwritten offering of 5,715,000 shares of its common stock and...
Jan 31, 2019 04:21 pm ET
Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it intends to offer for sale a combination of shares of its common stock and warrants...
Jan 28, 2019 08:30 am ET
New Clinical Trial Finds Milestone Scientific’s CompuFlo® Instrument a Safe Alternative to Current Standards of Care
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the results of a four hundred patient clinical trial by researchers from the...
Jan 25, 2019 04:05 pm ET
New York Stock Exchange Accepts Milestone Scientific’s Plan to Regain Compliance
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that the New York Stock Exchange has accepted the Company’s plan to regain...
Nov 26, 2018 08:30 am ET
Report: Exploring Fundamental Drivers Behind CSW Industrials, DMC Global, National HealthCare, Milestone Scientific, EnSync, and Trio-Tech International — New Horizons, Emerging Trends, and Upcoming D
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of CSW Industrials, Inc. (NASDAQ:CSWI), DMC Global Inc. (NASDAQ:BOOM),...
Nov 23, 2018 01:30 pm ET
Milestone Scientific Announces Recent Presentations Featuring The Wand® STA
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Dr. Glassman, Chief Dental Officer for Dental Corp., and Dr. Eugene Casagrande,...
Nov 19, 2018 08:00 am ET
Milestone Scientific Schedules Third Quarter 2018 Conference Call
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November...
Nov 15, 2018 09:10 am ET
Milestone Scientific Provides Business Update for the Third Quarter of 2018
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter and nine...
Nov 13, 2018 08:00 am ET
New Study Validates Milestone Scientific’s CompuFlo® Instrument for Epidural Space Identification in Difficult Patients
Milestone Scientific Inc. (NYSE: MLSS) today announced a new clinical study published in the International Journal of Obstetric Anesthesia that finds the CompuFlo® Epidural System to be successful in objectively identifying the epidural space—even...
Nov 05, 2018 08:30 am ET
Milestone Scientific Receives Notice of Allowance for New U.S. Patent
Milestone Scientific Inc. (NYSE: MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has received Notice of Allowance for a key patent from the U.S. Patent and Trademark...
Oct 23, 2018 08:00 am ET
Milestone Scientific Signs U.S. Distribution Agreement for the CompuFlo® Epidural System with Medical Device Distributor Clinical Technology, Inc.
Milestone Scientific Inc. (NYSE: MLSS), a developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has signed an agreement with Clinical Technology, Inc. (CTI), a leading specialty...
Aug 14, 2018 05:12 pm ET
Milestone Scientific Provides Business Update for the Second Quarter of 2018
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter and six...
Aug 10, 2018 01:11 pm ET
Milestone Scientific Schedules Second Quarter 2018 Conference Call
Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, August 15,...
Jul 03, 2018 07:00 am ET
Milestone Scientific CompuFlo® Epidural System Selected to Objectively Measure the Integrity of a High Fidelity Epidural Simulator in Real Time; Research Article Published in Prominent Scientific Peer
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that the CompuFlo® Epidural System was selected to objectively measure the integrity...
Jun 05, 2018 08:02 am ET
Milestone Scientific Features CompuFlo® Epidural System at Euroanaesthesia 2018
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported on interest generated in the CompuFlo® Epidural System at Euroanaesthesia 2018, the...
Jun 05, 2018 07:00 am ET
Milestone Scientific Continues Expansion of Distributor Network for the CompuFlo® Epidural System in the US; Adds Two Additional Independent Distributors Covering Territories within the Southwest and
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has signed agreements with two additional independent distributors for its...
May 29, 2018 07:00 am ET
Milestone Scientific Announces Two Additional Independent Distributors in the U.S. for CompuFlo® Epidural System
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has signed agreements with two additional independent distributors for its...
May 21, 2018 09:53 am ET
Milestone Scientific Announces Three Additional Independent Distributors in the U.S. for CompuFlo® Epidural System
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has signed agreements with three additional independent distributors for its...
May 15, 2018 04:30 pm ET
Milestone Scientific Provides Business Update for the First Quarter of 2018
Milestone Scientific Inc. (NYSE:MLSS), a dental and medical company that develops and commercializes a growing portfolio of proprietary injection technologies, today provided a business update and announced financial results for the first quarter...
May 14, 2018 07:00 am ET
Milestone Scientific Announces CompuFlo® Epidural System Sales Strategy for the U.S.; Enters Agreement with Leading Distributor Covering Key Midwestern Territories
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided an update on its unfolding sales strategy for the U.S., and announced it has signed an...
May 11, 2018 08:45 am ET
Milestone Scientific Schedules First Quarter 2018 Conference Call
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Wednesday, May 16,...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.